CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 31 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $404,000 | -52.0% | 505,702 | -42.4% | 0.00% | – |
| Q2 2018 | $841,000 | -8.5% | 877,476 | +72.7% | 0.00% | – |
| Q1 2018 | $919,000 | +174.3% | 508,106 | +125.5% | 0.00% | – |
| Q4 2017 | $335,000 | +4685.7% | 225,309 | +3923.4% | 0.00% | – |
| Q2 2017 | $7,000 | – | 5,600 | +2700.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 200 | -96.1% | 0.00% | – |
| Q2 2016 | $19,000 | +533.3% | 5,139 | +654.6% | 0.00% | – |
| Q1 2016 | $3,000 | -62.5% | 681 | -39.1% | 0.00% | – |
| Q4 2015 | $8,000 | -33.3% | 1,118 | -27.1% | 0.00% | – |
| Q3 2015 | $12,000 | -58.6% | 1,533 | -36.1% | 0.00% | – |
| Q2 2015 | $29,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,857,667 | $17,602,000 | 13.52% |
| Clarus Ventures, LLC | 2,752,488 | $16,955,000 | 10.42% |
| Cormorant Asset Management, LP | 800,000 | $4,928,000 | 0.54% |
| GREAT POINT PARTNERS LLC | 250,000 | $1,540,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 387,943 | $2,390,000 | 0.39% |
| Camber Capital Management LP | 1,000,000 | $6,160,000 | 0.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 683,375 | $4,210,000 | 0.20% |
| TLP GROUP LLC | 25,920 | $160,000 | 0.17% |
| Rhenman & Partners Asset Management AB | 100,000 | $616,000,000 | 0.10% |
| FT Options LLC | 17,736 | $109,000 | 0.09% |